Moderna stock rose sharply after the company reported initial results from a trial of a personalised mRNA cancer treatment used…
Browsing: mRNA
An AI-designed universal coronavirus vaccine has produced strong safety and cross-reactive immune response results in its first human trial, with researchers describing the outcome as an encouraging step toward broad coronavirus protection.